Page 36 - Read Online
P. 36
Page 108 Oquendo et al. J Transl Genet Genom 2021;5:89-111 https://dx.doi.org/10.20517/jtgg.2021.04
identifies a subset with distinct genotype. Leukemia 2015;29:1177-85. DOI PubMed
24. Parry M, Rose-Zerilli MJ, Ljungström V, et al. Genetics and Prognostication in Splenic Marginal Zone Lymphoma: Revelations from
Deep Sequencing. Clin Cancer Res 2015;21:4174-83. DOI PubMed PMC
25. Arribas AJ, Rinaldi A, Mensah AA, et al. DNA methylation profiling identifies two splenic marginal zone lymphoma subgroups with
different clinical and genetic features. Blood 2015;125:1922-31. DOI PubMed PMC
26. Arribas AJ, Bertoni F. Methylation patterns in marginal zone lymphoma. Best Pract Res Clin Haematol 2017;30:24-31. DOI
PubMed
27. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. Unmutated Ig VH genes are associated with a more aggressive form of
chronic lymphocytic leukemia. Blood 1999;94:1848-54. PubMed
28. Damle RN, Wasil T, Fais F, et al. Ig V Gene Mutation Status and CD38 Expression As Novel Prognostic Indicators in Chronic
Lymphocytic Leukemia. Blood 1999;94:1840-7. PubMed
29. Rinaldi A, Mian M, Chigrinova E, et al. Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific
lesions with an impact on the clinical outcome. Blood 2011;117:1595-604. DOI PubMed
30. Arcaini L, Zibellini S, Passamonti F, et al. Splenic marginal zone lymphoma: Clinical clustering of immunoglobulin heavy chain
repertoires. Blood Cells Mol Dis 2009;42:286-91. DOI PubMed
31. Salido M, Baró C, Oscier D, et al. Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell
lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group. Blood 2010;116:1479-88. DOI PubMed
32. Rossi D, Deaglio S, Dominguez-Sola D, et al. Alteration of BIRC3 and multiple other NF-κB pathway genes in splenic marginal zone
lymphoma. Blood 2011;118:4930-4. DOI PubMed
33. Piva R, Deaglio S, Famà R, et al. The Krüppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone
lymphoma. Leukemia 2015;29:503-7. DOI PubMed
34. Davoli T, Xu AW, Mengwasser KE, et al. Cumulative haploinsufficiency and triplosensitivity drive aneuploidy patterns and shape
the cancer genome. Cell 2013;155:948-62. DOI PubMed PMC
35. Sack LM, Davoli T, Li MZ, et al. Profound tissue specificity in proliferation control underlies cancer drivers and aneuploidy patterns.
Cell 2018;173:499-514.e23. DOI PubMed PMC
36. Watkins AJ, Huang Y, Ye H, et al. Splenic marginal zone lymphoma: characterization of 7q deletion and its value in diagnosis. J
Pathol 2010;220:461-74. DOI PubMed
37. Algara P, Mateo MS, Sanchez-Beato M, et al. Analysis of the IgV(H) somatic mutations in splenic marginal zone lymphoma defines
a group of unmutated cases with frequent 7q deletion and adverse clinical course. Blood 2002;99:1299-304. DOI PubMed
38. Fresquet V, Robles EF, Parker A, et al. High-throughput sequencing analysis of the chromosome 7q32 deletion reveals IRF5 as a
potential tumour suppressor in splenic marginal-zone lymphoma. Br J Haematol 2012;158:712-26. DOI PubMed
39. Hosono N, Makishima H, Mahfouz R, et al. Recurrent genetic defects on chromosome 5q in myeloid neoplasms. Oncotarget
2017;8:6483-95. DOI PubMed PMC
40. Venugopal S, Mascarenhas J, Steensma DP. Loss of 5q in myeloid malignancies - A gain in understanding of biological and clinical
consequences. Blood Rev 2021;46:100735. DOI PubMed
41. Dierlamm J, Rosenberg C, Stul M, et al. Characteristic pattern of chromosomal gains and losses in marginal zone B cell lymphoma
detected by comparative genomic hybridization. Leukemia 1997;11:747-58. DOI PubMed
42. Dierlamm J, Michaux L, Wlodarska I, et al. Trisomy 3 in marginal zone B-cell lymphoma: a study based on cytogenetic analysis and
fluorescence in situ hybridization. Br J Haematol 1996;93:242-9. DOI PubMed
43. Hernández JM, García JL, Gutiérrez NC, et al. Novel genomic imbalances in B-Cell splenic marginal zone lymphomas revealed by
comparative genomic hybridization and cytogenetics. Am J Pathol 2001;158:1843-50. DOI PubMed PMC
44. Solé F, Woessner S, Florensa L, et al. Frequent involvement of chromosomes 1, 3, 7 and 8 in splenic marginal zone B-cell
lymphoma. Br J Haematol 1997;98:446-9. DOI PubMed
45. Troussard X, Mauvieux L, Radford-Weiss I, et al. Genetic analysis of splenic lymphoma with villous lymphocytes: a Groupe Français
d'Hématologie Cellulaire (GFHC) study. Br J Haematol 1998;101:712-21. DOI PubMed
46. Robledo C, García JL, Benito R, et al. Molecular characterization of the region 7q22.1 in splenic marginal zone lymphomas. PLoS
One 2011;6:e24939. DOI PubMed PMC
47. Gailllard B, Cornillet-Lefebvre P, Le QH, et al; Groupe Francophone de Cytogénétique Hématologique. Clinical and biological
features of B-cell neoplasms with CDK6 translocations: an association with a subgroup of splenic marginal zone lymphomas
displaying frequent CD5 expression, prolymphocytic cells, and TP53 abnormalities. Br J Haematol 2021;193:72-82. DOI PubMed
48. Hoang PH, Dobbins SE, Cornish AJ, et al. Whole-genome sequencing of multiple myeloma reveals oncogenic pathways are targeted
somatically through multiple mechanisms. Leukemia 2018;32:2459-70. DOI PubMed PMC
49. Burns A, Alsolami R, Becq J, et al. Whole-genome sequencing of chronic lymphocytic leukaemia reveals distinct differences in the
mutational landscape between IgHVmut and IgHVunmut subgroups. Leukemia 2018;32:332-42. DOI PubMed PMC
50. Arthur SE, Jiang A, Grande BM, et al. Genome-wide discovery of somatic regulatory variants in diffuse large B-cell lymphoma. Nat
Commun 2018;9:4001. DOI PubMed PMC
51. Quesada V, Conde L, Villamor N, et al. Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in
chronic lymphocytic leukemia. Nat Genet 2011;44:47-52. DOI PubMed
52. Puente XS, Pinyol M, Quesada V, et al. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia.
Nature 2011;475:101-5. DOI PubMed PMC
53. Oquendo C, Parker H, Oscier D, Ennis S, Gibson J, Strefford JC. Systematic Review of Somatic Mutations in Splenic Marginal Zone